Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
about
Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal CancersmTOR kinase inhibitors as potential cancer therapeutic drugsGenotype directed therapy in murine mismatch repair deficient tumorsPP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathwayCombination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinomaImpact of the mitogen-activated protein kinase pathway on the subproteome of detergent-resistant microdomains of colon carcinoma cells.Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosisBlockage of Autophagy Rescues the Dual PI3K/mTOR Inhibitor BEZ235-induced Growth Inhibition of Colorectal Cancer Cells.Microbial synthesized biodegradable PHBHHxPEG hybrid copolymer as an efficient intracellular delivery nanocarrier for kinase inhibitor.mTOR pathway in colorectal cancer: an update.Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase ActivityIncomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitorsSelective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells.Invitro Evaluation of Torin2 and 2, 6-Dihydroxyacetophenone in Colorectal Cancer Therapy.Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations.
P2860
Q26781362-C45A9CDC-ECF3-4195-B213-4A29446EFE11Q27027963-2C51B87D-8D08-4EE4-A458-374DB656513AQ28534803-60A9A7F7-F6A9-4511-BFD7-B90D7B319803Q34465116-EC89E6EF-30EC-49BF-B3DF-B7AC63DC4B84Q34977124-6682055E-9AF1-4A05-9699-5007F87C52F3Q35379875-CA6BBEDB-A8B4-46AA-B7D2-0FC713D3584BQ36516580-9E05A0BE-61EB-4660-97D3-0094225CC9EEQ36985432-0595370B-9040-4976-AC2D-0CFA875B1A82Q37539595-E7BEFE37-2FD4-40FF-BB45-C21489AFD204Q37649634-D4B94160-D9CA-4157-9CF0-2407C52E9939Q37661161-888B021A-B8E6-4BF1-84AA-E453D5B6A383Q37696682-CEF08A72-94B5-4229-8C5C-AE0041B29D3BQ39067602-6999AA1C-2EF2-4B74-A35C-27E4FC52E3BDQ42381878-B1998AD5-9BCE-4109-8ED2-82D5B07D07E3Q48364896-EC9CB089-8991-41EE-A3E8-E2F11E3E3906Q55332287-1BF3BBDB-38FD-45F0-8A5A-19C688F0D038
P2860
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@ast
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@en
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@nl
type
label
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@ast
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@en
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@nl
prefLabel
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@ast
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@en
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells.
@en
P2093
Anne Dormond-Meuwly
Benjamin Blaser
Didier Roulin
Laurent Waselle
Marc Dufour
Nicolas Demartines
Olivier Dormond
P2860
P2888
P356
10.1186/1471-2407-12-86
P407
P577
2012-03-08T00:00:00Z
P5875
P6179
1003135716